Genetic prognostic markers for acute myeloid leukemia with normal cytogenetics / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 436-439, 2011.
Article
in Chinese
| WPRIM
| ID: wpr-472130
ABSTRACT
Acute myeloid leukemia (AML) is a heterogenous disorder disease, about 40 %-49 % of the adult AML and 25 % of children had normal karyotype AML, and usually categorized as an intermediaterisk group, but for acquired genetic change, such as mutations of FLT3, NPM1, CEBPα, MLL, and KIT as well as alterations in expression levels of BAALC, MN1, ERG, and EVI1, leading to significant heterogeneity for the prognosis of this group. In this report, prognostic genetic findings in normal karyotypical AML and discuss their clinical implications was reviewed.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Prognostic study
Language:
Chinese
Journal:
Journal of Leukemia & Lymphoma
Year:
2011
Type:
Article
Similar
MEDLINE
...
LILACS
LIS